U.S. Clinical Trial Supply and Logistics Market Revenue to Attain USD 2.30 Bn by 2033

13 Dec 2024

Share :

Table of Content

1. U.S. Clinical Trial Supply and Logistics Market Revenue and Trends 2023 to 2033 2. Market Overview 3. Report Highlights of the U.S. Clinical Trial Supply and Logistics Market 4. Major Trends in the U.S. Clinical Trial Supply and Logistics Market  5. U.S. Clinical Trial Supply And Logistics Market Coverage 6. U.S. Clinical Trial Supply And Logistics Market Players 7. Market News  

U.S. Clinical Trial Supply and Logistics Market Revenue and Trends 2023 to 2033

The U.S. clinical trial supply and logistics market revenue reached USD 1.19 billion in 2024 and is predicted to attain around USD 2.30 billion by 2033 with a CAGR of 7.58%.

Market Overview

Clinical trial supply and logistics encompass a comprehensive framework involving the meticulous planning, management, and execution of various critical processes for the success of clinical trials. This includes procuring pharmaceutical products, medical devices, and other essential materials necessary for research and testing. The logistics process starts with carefully selecting suppliers and manufacturers, ensuring that all products meet regulatory standards and are of high quality. Once procured, these materials require secure storage that adheres to specific environmental controls, such as temperature and humidity, to maintain their integrity.

Distribution is another crucial aspect, which involves strategically planning transportation methods to ensure timely and efficient delivery to trial sites. This process must consider geographical factors, local regulations, and the need for cold chain management if applicable. Additionally, tracking systems are implemented to monitor the movement of supplies from the point of origin to the clinical trial site. This includes maintaining accurate documentation and inventory control to prevent shortages or discrepancies. By effectively managing these elements, clinical trial supply and logistics play a vital role in ensuring that trials run smoothly, meet timelines, and ultimately contribute to the advancement of medical research. The market is experiencing significant growth due to the rising clinical trials and increasing demand for precision medicines.

Report Highlights of the U.S. Clinical Trial Supply and Logistics Market

• By service, the logistics & distribution segment dominated the market with the largest share in 2023. The logistics & distribution segment plays a vital role in successfully executing clinical trials. This aspect ensures that investigational products and essential materials are not only transported efficiently but also delivered to the appropriate locations within time. Maintaining strict compliance with regulatory standards throughout this process is crucial, as it safeguards the integrity of the trial and guarantees that the necessary resources are available when needed. This complex network of transportation and handling requires careful planning and coordination to meet the demands of the trial while upholding the highest safety and quality standards.
• By phase, the phase III segment accounted for the largest market share in 2023. Phase III clinical trials are characterized by their substantial scale, often engaging a diverse and large cohort of participants. These trials frequently occur across numerous sites and multiple countries, enhancing the breadth and applicability of the findings. The intricacies and demands of Phase III trials necessitate meticulous planning and robust logistical support. This careful coordination is crucial to guarantee that investigational products are delivered promptly and efficiently to each trial site, ensuring that the study can proceed without delays and that data collection is both accurate and consistent.
• By end-user, the pharmaceuticals segment dominated the market in 2023. The pharmaceutical industry heavily depends on clinical trials as a fundamental process to establish both the safety and effectiveness of new drugs and therapeutic interventions. These trials involve human participants and are conducted in several phases to assess various factors, such as dosage, side effects, and overall therapeutic benefits. Each phase of a clinical trial serves a specific purpose, starting with Phase I, which focuses on safety and dosage, moving to Phase II, where the drug's efficacy is evaluated, and culminating in Phase III, which involves larger population to confirm effectiveness and monitor adverse reactions. The data collected from these trials are essential for regulatory approval and critical in informing healthcare providers and patients about new medications' potential benefits and risks.
• By therapeutics area, the cardiovascular diseases segment led the U.S. clinical trial supply and logistics market in 2023. This is mainly due to the increasing incidence of cardiovascular diseases, which has become a pressing public health concern. Contributing factors include an aging population, rising levels of obesity, sedentary lifestyles, and unhealthy dietary habits, all of which exacerbate the prevalence of conditions such as hypertension, coronary artery disease, and heart failure. As awareness of these health issues continues to grow and advancements in treatment options emerge, the demand for cardiovascular-related products and services is expected to surge, further solidifying this segment's leading position in the market.

Major Trends in the U.S. Clinical Trial Supply and Logistics Market 

Rising Adoption of AI and ML

Clinical research organizations and pharmaceutical companies are increasingly harnessing the power of artificial intelligence (AI) to streamline and automate multiple processes involved in clinical trials. This integration not only alleviates the workload for staff members but also significantly minimizes the risk of errors, thereby enhancing the overall efficiency of the trials. By employing advanced machine learning (ML) algorithms and computer vision technologies, these organizations are able to analyze vast datasets rapidly and effectively. This capability allows for the swift identification and screening of potential drug candidates, which is critical in the time-sensitive pharmaceutical development pipeline. As a result, researchers can focus more on strategic decision-making and innovation, while AI-driven tools handle the more labor-intensive aspects of data processing and analysis.

Increasing Clinical Trials

With the increase in clinical trials, the volume of clinical data is surging at an unprecedented rate, prompting a heightened need for sophisticated medical trial data management tools. This surge can be attributed to the emergence of big data technologies, which facilitate advanced predictive modeling of complex biological processes and the effects of various drugs. As a result, research organizations are increasingly harnessing the potential of electronic health records (EHRs) to conduct in-depth analyses aimed at identifying the most suitable candidates for participation in clinical trials. By leveraging the wealth of information contained within EHRs, such as patient demographics, medical histories, and treatment outcomes, these organizations aim to optimize patient selection, enhance the efficiency of clinical trials, and ultimately improve the development of new therapies.

U.S. Clinical Trial Supply And Logistics Market Coverage

U.S. Clinical Trial Supply And Logistics Market Players

• Almac Group
• DHL
• Parexel
• Thermo Fisher Scientific (Patheon)
• Marken
• Piramal Pharma Solutions
• UDG Healthcare
• Catalent, Inc.
• FedEx
• Movianto
• Packaging Coordinators Inc.

Market News  

• In February 2024, Experic, a US-based contract development and manufacturing organization (CDMO) and clinical trial supply services company serving the biopharmaceutical industry, established its new facility in Dublin, Ireland, to support global clinical trials.

Market Segmentation

By Service

• Logistics & Distribution
• Storage & Retention
• Packaging, Labeling, and Blinding
• Manufacturing
• Comparator Sourcing
• Others

By Phase

• Phase I
• Phase II
• Phase III
• Phase IV

By End-user

• Pharmaceuticals
• Biologicals
• Medical Device

By Therapeutic Area

• Oncology
• Cardiovascular Diseases
• Respiratory Diseases
• CNS and Mental Disorders
• Others

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344